Primary Site >> Pancreatic Cancer
Gene >> RUNX3
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. PMID: 14743205 Ref: RUNX3 expression in primary and metastatic pancreatic cancer. PMID: 14990603 |
Ref: Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). PMID: 17089004 |
Ref: Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system. PMID: 17278096 |
Ref: Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation. PMID: 18430739 Ref: Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer. PMID: 18475302 |
Ref: A novel HMM-based method for detecting enriched transcription factor binding sites reveals RUNX3 as a potential target in pancreatic cancer biology. PMID: 21203558 |
Ref: RAS oncogenic signal upregulates EZH2 in pancreatic cancer. PMID: 22222375 |
Ref: Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids. PMID: 23555160 Ref: [Effect of 5-aza-2'-deoxycytidine on growth and methylation of RUNX3 gene in human pancreatic cancer cell line MiaPaca2]. PMID: 23648294 Ref: Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer. PMID: 23664167 |
Ref: Expression of RUNX3 gene in pancreatic adenocarcinoma and its clinical significance. PMID: 24938604 |
Ref: RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. PMID: 26004068 Ref: It's a SMAD/SMAD World. PMID: 26046433 |
Ref: RUNX3 defines disease behavior in pancreatic ductal adenocarcinoma. PMID: 27308599 |
Ref: Runx3 and Cell Fate Decisions in Pancreas Cancer. PMID: 28299667 Ref: Runx3 in Immunity, Inflammation and Cancer. PMID: 28299669 Ref: RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer. PMID: 28882948 |
Ref: Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors. PMID: 29533787 |